Recent advances and controversies in surgical management of hepatocellular carcinoma of hepatocellular carcinoma / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 378-380, 2008.
Artículo
en Chino
| WPRIM
| ID: wpr-270685
ABSTRACT
Surgical treatment of hepatocellular carcinoma (HCC) has made great progress in recent ten years, although the appropriate selection of treatment methods remains controversial. Surgical resection of HCC is still widely recognized as the first choice, which has been remarkably improved by effectively controlling intra-operative bleeding. However, the ischemia/reperfusion injury and long-term recurrence still proposes challenges to Pringle's maneuver. The indications of liver transplantation also expand in recent years, and many centers have used marginal donor liver and living donor liver. Remission of the shortage of donors, local ablation of small HCC, and surgical resection still lack the support of randomized controlled trials. In summary, the surgical treatment of HCC should strictly based on the indications of various therapies, which should be prudently verified by randomized controlled trials.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patología
/
Cirugía General
/
Ensayos Clínicos Controlados Aleatorios como Asunto
/
Trasplante de Hígado
/
Carcinoma Hepatocelular
/
Complicaciones Intraoperatorias
/
Neoplasias Hepáticas
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Humanos
Idioma:
Chino
Revista:
Acta Academiae Medicinae Sinicae
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS